We are live on ! Find out more
BRA

Bender Robert & Associates Portfolio holdings

AUM $417M
1-Year Est. Return 25.02%
This Fund
S&P 500
This Quarter Est. Return
+17.29%
1 Year Est. Return
+25.02%
3 Year Est. Return
+98.12%
5 Year Est. Return
+139.29%
10 Year Est. Return
+812.75%
AUM
$362M
AUM Growth
+$39.2M
Cap. Flow
-$5.52M
Cap. Flow %
-1.52%
Top 10 Hldgs %
70.9%
Holding
56
New
1
Increased
10
Reduced
33
Closed
6

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$4.05M
2
LLY icon
Eli Lilly
LLY
+$3.61M
3
NOW icon
ServiceNow
NOW
+$258K
4
MSFT icon
Microsoft
MSFT
+$201K
5
FIVE icon
Five Below
FIVE
+$166K

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$2.54M
2
AAPL icon
Apple
AAPL
+$2.34M
3
VMW
VMware, Inc
VMW
+$1.87M
4
AZN icon
AstraZeneca
AZN
+$932K
5
CTSH icon
Cognizant
CTSH
+$877K

Sector Composition

Rank Sector Weight
1 Technology 43.09%
2 Consumer Discretionary 25.56%
3 Healthcare 19.87%
4 Communication Services 9.51%
5 Utilities 0.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTSH icon
51
Cognizant
CTSH
$22.3B
-14,399
Closed -$877K
NSC icon
52
Norfolk Southern
NSC
$77.1B
-2,826
Closed -$599K
TROW icon
53
T. Rowe Price
TROW
$25.5B
-2,135
Closed -$241K
VMW
54
DELISTED
VMware, Inc
VMW
-14,981
Closed -$1.87M
BBIG
55
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
-4,000
Closed -$25.7K
JNCE
56
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
-10,000
Closed -$18.5K

Similar funds

Bender Robert & Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Bender Robert & Associates held 56 positions worth $362M, up 12% from $323M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Bender Robert & Associates's Q2 2023 filing shows 1 new, 10 increased, 33 reduced and 6 closed positions. Its largest new stake was Pulse Biosciences: 10,325 shares worth $74.2K. The largest sale was AbbVie, an estimated $2.54M.

By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 39% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Bender Robert & Associates's largest Q2 2023 buy was Pulse Biosciences: 10,325 shares worth $74.2K.
  • Bender Robert & Associates added most to Advanced Micro Devices in Q2 2023, an estimated $4.05M increase.
  • Bender Robert & Associates's biggest Q2 2023 reduction was AbbVie, cutting an estimated $2.54M.
  • Bender Robert & Associates fully exited VMware, Inc in Q2 2023, selling an estimated $1.87M.
  • Bender Robert & Associates's ten largest holdings make up 71% of its $362M portfolio in Q2 2023.
  • Bender Robert & Associates opened 1 new position and closed 6 in Q2 2023.
  • Bender Robert & Associates's portfolio value rose 12% quarter-over-quarter to $362M.

Based on Bender Robert & Associates's 13F filing for Q2 2023, filed 14 Jul 2023.